The Shift Toward Gentler and More Effective Cancer Treatments
The pharmaceutical industry is in the midst of a significant shift as antibody-drug conjugates (ADCs) emerge as a promising alternative to traditional chemotherapy for cancer
Home
Page 95
JPMorgan Chase Bets on Premium Benefits to Retain Affluent Clients
JPMorgan Chase (NYSE: JPM) is making a big move with its Sapphire Reserve credit card, hoping that a fresh slate of premium benefits will keep
Karbon-X and Directions Group Team Up to Turn Alberta Homes into Carbon Credit Generators
Karbon-X Corp. (OTCQX: KARX), a climate solutions company, is partnering with Directions Group Inc., a Canadian clean energy consultancy, to launch a new residential solar
Solar Stocks Slide After Senate Budget Bill Targets Tax Credits
Solar stocks took a sharp hit in early trading Tuesday, following the release of a Senate budget bill that aims to phase out tax credits
Endo Sells International Pharmaceuticals Business to Knight Therapeutics for $105 Million
Endo, Inc. (OTCQX: NDOI) has wrapped up the sale of its International Pharmaceuticals business, marking a significant shift in the company’s focus and portfolio. The
Nevada Canyon’s Strategic Sale of Swales Property Positions for Growth
Nevada Canyon Gold Corp. (OTCQX: NGLD) has finalized the sale of its Swales Gold Property lease to Metals One Nevada Inc., a subsidiary of Metals
NASA and India Join Forces to Launch Advanced Earth Observation Satellite
NASA is set to launch a groundbreaking satellite in collaboration with India, marking a significant advancement in Earth observation technology. The satellite, named NISAR, is
Tonix Pharmaceuticals Advances New Non-Opioid Treatment for Fibromyalgia
Tonix Pharmaceuticals (NASDAQ: TNXP) is on the cusp of a potential breakthrough in fibromyalgia treatment with its investigational drug TNX-102 SL. The sublingual formulation of
